LLY

ELI LILLY & CO

LLY·532457108·US·Common Stock·Healthcare - Drug Manufacturers - General-13D/G

LLY institutional ownership changes in Q2 2026: 242 institutions opened or added positions, 164 trimmed or exited. LLY (ELI LILLY & CO) is held by 410 institutional investors as of Q2 2026. Top institutional shareholders: LILLY ENDOWMENT INC ($108.4B), BlackRock, Inc. ($81B), VANGUARD CAPITAL MANAGEMENT LLC ($64.2B). Net institutional sentiment: Mixed. In Q2 2026, 2 members of Congress and 242 funds bought LLY.

410
Holders
(43 Elite)
$881.6B
Total Value
60% (406)
Consensus
242 buying - 164 selling
13F: Insider & Congress: Updated regularly
LLY

Smart Money Verdict

View all
Loading verdict
Held by 410 funds
43 elite

Who's Trading

Source dates: Price Oct 28, 2026 · Insiders Oct 20, 2026 · Activists Oct 19, 2026 · Congress Aug 24, 2026

InsiderARAlvarez RalphVest 10.011 shOct 19, 2026
InsiderFEFyrwald J ErikVest 7.995 shOct 19, 2026
ActivistLILLY ENDOWMENT, INC.LILLY ENDOWMENT, INC.9.6%Oct 19, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
90.4M(-1.6%)$108.4B100.0%+913.96%
0
Increased
67.5M(+1.8%)$81B1.2%+46.42%
51
Increased
53.5M(+0.3%)$64.2B1.4%+40.38%
50
Decreased
51.3M(-0.0%)$61.6B30.5%+166.57%
0
Increased
36.2M(+1.7%)$43.4B1.3%+590.53%
51
Increased
28.5M(+8.1%)$34.1B1.5%+297.48%
54
Decreased
20.9M(-15.3%)$25B3.5%+95.61%
0
Decreased
20.9M(-0.6%)$25B1.1%+40.51%
0
Increased
20.3M(+0.6%)$24.3B1.3%+309.26%
50
Increased
16.2M(+5.1%)$19.5B1.0%+42.32%
53
Increased
15.9M(+1.8%)$19.1B2.3%+375.20%
56
Decreased
13.9M(-0.6%)$16.7B1.7%+328.64%
0
Decreased
12.6M(-8.0%)$15.5B0.9%+40.81%
0
Increased
11.3M(+1.3%)$13.5B0.9%+179.85%
45
Decreased
11M(-18.1%)$13.2B2.3%+330.28%
0
Unchanged
10.8M$12.9B8.8%+1129.60%
0
Decreased
9.2M(-0.6%)$11B6.5%+1128.25%
0
Decreased
8.8M(-0.3%)$10.6B1.2%+479.49%
0
Increased
7.7M(+20.7%)$9.2B0.8%+104.23%
54
Increased
7.2M(+1.9%)$8.6B1.6%+150.80%
51

Showing 1-20 of 415

1 / 21
LLYLLYELI LILLY & CO

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used